|
|
Miscellaneous articles
|
Non-travel-related monkey bites in Marseille,
France |
 |
P. Gautret1 , E. Adehossi2,
J.-C. Gérard3, and P. Parola1
1Service
des Maladies Infectieuses et Tropicales, Hôpital
Nord, AP-HM, 13015 Marseille, France;
philippe.gautret@club-internet.fr
2Faculté
des Sciences de la Santé, Université de Niamey,
Niger.
3Espace
Zoologique, 42800 Saint Martin La Plaine,
France.
Observation
On 01/07/2008, a 19 year-old woman
while walking along the streets in Marseille, was
attacked by a free roaming monkey which ran away
after biting her. She took a picture of the animal
with her mobile phone and noticed that the animal
had a necklace and a lead. She consulted her general
practitioner and was referred to the Rabies
Vaccination Centre, 2 days later. On admission, she
presented 4 minor wounds on her arms, one foot and
her face. The wounds were washed and disinfectant
was applied on the day of injury. Amoxicillin-clavulanic
acid based antibiotherapy was ongoing. Rabies post
exposure prophylaxis (PEP) by vaccination only was
applied with a 2.1.1 intra-muscular regimen, using
Vero-cell cultured vaccine. The patient remained
well over the 3 month-follow up. On examination of
the picture, the monkey was identified as a young
Barbary macaque (Macaca sylvanus). On 10/07/2008, a
2 year-old female Barbary macaque with necklace and
lead was captured on a Marseille beach and
transferred to a zoo on 17/07/2008 (figure 1). The
monkey’s clinical examination was normal and the
animal remained safe over the 3 following months.
Serologic test for rabies resulted positive (7.92
UI/ml) suggesting that the animal had been very
likely vaccinated previously against rabies, given
its absence of neurological symptoms and the high
titre of antibodies. However antibodies resulting
from a preventive vaccination cannot be
distinguished from antibodies resulting from rabies
infection and the animal was therefore kept under
quarantine for 6 month duration to comply with
French legislation. Serologic tests against common
viruses in macaques were performed. They were not
reactive for herpes B virus (Cercopithecine
Herpesvirus 1), hepatitis A and B viruses, simian
immunodeficiency virus (SIV), simian T-cell
lymphotrophic virus and type D retrovirus (SRV).
Like hepatitis A and B viruses, herpes B virus, SIV
and SRV can infect humans.
Discussion
Rabies cases in humans resulting from
transmission by rabid non-human primate (NHP) are
rare [1-3] but 8 human fatal rabies cases related to
Brazilian white-tufted-ear rabid marmoset-related
injuries (Callithrix jacchus) were recently
published [4]. WHO and CDC provide no guidelines
regarding rabies PEP following NHP-related injuries.
We consider that NHP living in rabies endemic
countries could potentially be infected by the
rabies virus. A rabies PEP treatment should be
offered when the involved animal cannot be kept
under veterinarian surveillance or tested for
rabies. This is in accordance with practice in
canine rabies-endemic areas where NHP-related
injuries are common [5,6]. Barbary macaque is a
unique species that occurs in Morocco and Algeria
and settled a colony in Gibraltar. Therefore, the
Marseille monkey had been very likely imported from
these countries which are endemic for rabies.
A total of 50 patients injured by NHP
were seen in our centre from March 2001 through
December 2008, involving travellers injured abroad
in 83% of cases. Among NHP-related injuries acquired
abroad, 33% occurred in Thailand, 20% in other Asian
countries, 32% in sub-Saharan Africa, 10% in North
Africa and 5% in Latin America. Ten cases were
acquired near Marseille involving principally
pet-Barbary macaques from Morocco and pet-capuchin
monkeys from Brazil.
We report here the first fully
documented case of monkey-related injury occurring
in Marseille where free-roaming NHP are not
expected. The Barbary Macaque has been facing a
decline in numbers over recent decades, fuelled in
large part by their demand for the illegal pet
trade. An estimated 300 animals are caught from the
wild annually for the illegal trade into Europe,
mainly in Morocco. Although most of the trade
concerns France, it exists in several other European
countries such as Belgium, Germany, the Netherlands
and Italy [7]. Barbary macaque have never been found
infected with B virus [8], a naturally occurring
infectious agent that is endemic among macaque
monkeys from Asia [9] but is naturally infected with
simian foamy virus which does not seem to cause any
illness in humans [8].
Conclusion
NHP account for 20% of animal-related
injuries in travellers [10] and the illegal
introduction of exotic monkey-pets in Europe will
contribute to expose the population to increasing
monkey-human interactions and potential dangerous
zoonosis transmission like rabies and herpes B virus
infection.
References
-
Wilson JM, Hettiarachchi J,
Wijesuriya LM. Presenting features and diagnosis of
rabies. Lancet 1975;2:1139-40.
-
Centers for Diseases Control
(CDC). Imported human rabies--Australia, 1987. MMWR
Morb Mortal Wkly Rep. 1988 Jun 10; 37(22):351-3.
-
Summer R, Ross S, Kiehl W.
Imported case of rabies in Germany from India. Euro
Surveill. 2004;8: 2585.
-
Favoretto SR, de Mattos CC, Morais
BB, Alves FA, Araujo AA, de Mattost CA. Rabies in
Marmosets (Callithrix jacchus), Ceara, Brazil. Emerg
Infect Dis. 2001;7:1062-1065.
-
Pandey P, Shlim D, Cave W,
Springer MFB. Risk of possible exposure to rabies
among tourist and foreign visitors in Nepal. J
Travel Med. 2002; 9: 127-131.
-
Sriaroon C, Jaijaroensup W,
Tantawichien T, Benjawongkunchai M, Supich C, Wilde
H. Common dilemmas in managing rabies exposed
subjects. Travel Med Infect Dis. 2005;3:1-7.
-
van Lavieren E. The illegal trade
in Barbary macaques from Morocco and its impact on
the wild population. Traffic bull. 2008; 21:81-88.
Available from www.traffic.org/bulletin/
-
Engel GA, Pizarro M, Shaw E,
Cortes J, Fuentes A, Barry P, Lerche N, Grant R,
Cohn D, Jones-Engel L. Unique Pattern of Enzootic
Primate Viruses in Gibraltar Macaques. Emerg Infect
Dis. 2008;14:1112-1115.
-
Cohen JI, Davenport DS, Stewart JA,
Deitchman S, Hilliard JK, Chapman LE; B Virus
Working Group. Recommendations for prevention of and
therapy for exposure to B virus (cercopithecine
herpesvirus 1). Clin Infect Dis. 2002;35:1191-203.
-
Gautret P, Schwartz E, Shaw M,
Soula G, Gazin P, Delmont J, Parola P, Soavi MJ,
Matchettt E, Brown G and Torresi J.
Animal-associated injuries and related diseases
among returned travelers: A review of the
GeoSentinel Surveillance Network. Vaccine. 2007;
25:2656-2663.
Acknowledgements
We thank the Société Française de
Primatologie (http://www-sfdp.u-strasbg.fr/) for the
identification and localization of the monkey.
Contents of this Bulletin
|